CN102977142A - 福沙匹坦二甲葡胺的制备方法 - Google Patents
福沙匹坦二甲葡胺的制备方法 Download PDFInfo
- Publication number
- CN102977142A CN102977142A CN2011102579706A CN201110257970A CN102977142A CN 102977142 A CN102977142 A CN 102977142A CN 2011102579706 A CN2011102579706 A CN 2011102579706A CN 201110257970 A CN201110257970 A CN 201110257970A CN 102977142 A CN102977142 A CN 102977142A
- Authority
- CN
- China
- Prior art keywords
- preparation
- compound
- formula
- sodium
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Saccharide Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110257970.6A CN102977142B (zh) | 2011-09-02 | 2011-09-02 | 福沙匹坦二甲葡胺的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110257970.6A CN102977142B (zh) | 2011-09-02 | 2011-09-02 | 福沙匹坦二甲葡胺的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102977142A true CN102977142A (zh) | 2013-03-20 |
CN102977142B CN102977142B (zh) | 2017-03-29 |
Family
ID=47851532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110257970.6A Active CN102977142B (zh) | 2011-09-02 | 2011-09-02 | 福沙匹坦二甲葡胺的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102977142B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103204878A (zh) * | 2013-03-29 | 2013-07-17 | 山东罗欣药业股份有限公司 | 一种福沙吡坦二甲葡胺的合成方法 |
CN106432337A (zh) * | 2015-08-08 | 2017-02-22 | 陕西合成药业股份有限公司 | 福沙匹坦衍生物、合成和在长效制剂中的用途 |
CN111662329A (zh) * | 2020-06-22 | 2020-09-15 | 连云港贵科药业有限公司 | 一种福沙匹坦双葡甲胺的合成方法 |
CN113583044A (zh) * | 2021-06-15 | 2021-11-02 | 山东罗欣药业集团股份有限公司 | 一种用于预防化疗相关性恶心呕吐的药物的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1147254A (zh) * | 1994-03-04 | 1997-04-09 | 麦克公司 | 吗啉速激肽受体拮抗剂的前药 |
CN101056672A (zh) * | 2004-11-05 | 2007-10-17 | 默克公司 | 制备{3-[2(r)-[(1r)-1-[3,5-二(三氟甲基)苯基]乙氧基]-3(s)-(4-氟苯基)吗啉-4-基 ]甲基]-5-氧代-4,5-二氢-[1,2,4]-三唑-1-基}膦酸的方法 |
WO2010018595A2 (en) * | 2008-07-17 | 2010-02-18 | Glenmark Generics Limited | Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations |
WO2011045817A2 (en) * | 2009-10-15 | 2011-04-21 | Sandoz Private Limited | Process for the preparation of fosaprepitant, intermediate and pharmaceutical acceptable salt thereof |
-
2011
- 2011-09-02 CN CN201110257970.6A patent/CN102977142B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1147254A (zh) * | 1994-03-04 | 1997-04-09 | 麦克公司 | 吗啉速激肽受体拮抗剂的前药 |
CN101056672A (zh) * | 2004-11-05 | 2007-10-17 | 默克公司 | 制备{3-[2(r)-[(1r)-1-[3,5-二(三氟甲基)苯基]乙氧基]-3(s)-(4-氟苯基)吗啉-4-基 ]甲基]-5-氧代-4,5-二氢-[1,2,4]-三唑-1-基}膦酸的方法 |
WO2010018595A2 (en) * | 2008-07-17 | 2010-02-18 | Glenmark Generics Limited | Fosaprepitant dimeglumine intermediate, neutral fosaprepitant, and amorphous fosaprepitant dimeglumine and processes for their preparations |
WO2011045817A2 (en) * | 2009-10-15 | 2011-04-21 | Sandoz Private Limited | Process for the preparation of fosaprepitant, intermediate and pharmaceutical acceptable salt thereof |
Non-Patent Citations (1)
Title |
---|
JEFFREY J. HALE ET AL.: "Phosphorylated Morpholine Acetal Human Neurokinin-1 Receptor Antagonists as Water-Soluble Prodrugs", 《J. MED. CHEM.》, vol. 43, 25 February 2000 (2000-02-25), XP009066442, DOI: doi:10.1021/jm990617v * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103204878A (zh) * | 2013-03-29 | 2013-07-17 | 山东罗欣药业股份有限公司 | 一种福沙吡坦二甲葡胺的合成方法 |
CN106432337A (zh) * | 2015-08-08 | 2017-02-22 | 陕西合成药业股份有限公司 | 福沙匹坦衍生物、合成和在长效制剂中的用途 |
CN111662329A (zh) * | 2020-06-22 | 2020-09-15 | 连云港贵科药业有限公司 | 一种福沙匹坦双葡甲胺的合成方法 |
CN111662329B (zh) * | 2020-06-22 | 2021-03-30 | 连云港贵科药业有限公司 | 一种福沙匹坦双葡甲胺的合成方法 |
CN113583044A (zh) * | 2021-06-15 | 2021-11-02 | 山东罗欣药业集团股份有限公司 | 一种用于预防化疗相关性恶心呕吐的药物的制备方法 |
CN113583044B (zh) * | 2021-06-15 | 2023-11-14 | 山东罗欣药业集团股份有限公司 | 一种用于预防化疗相关性恶心呕吐的药物的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102977142B (zh) | 2017-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI812770B (zh) | 新穎雜環化合物 | |
AU2017382360B2 (en) | Compounds, compositions and methods of use | |
CN103030668A (zh) | 一种制备福沙匹坦二甲葡胺的方法 | |
CA2925889C (en) | Hydrochloride salt form for ezh2 inhibition | |
JP5586632B2 (ja) | 5員の複素環式化合物のアザスピラニル−アルキルカルバメートの誘導体、この調製およびこの治療的使用 | |
CA2935880A1 (en) | Indazole compounds as irak4 inhibitors | |
JP2022547952A (ja) | Brd9二機能性分解誘導薬及びその使用方法 | |
WO2021213317A1 (zh) | Hpk1抑制剂及其制备方法和用途 | |
JP2022549810A (ja) | 複素環化合物 | |
CN113784963A (zh) | 用作ret激酶抑制剂的化合物及其应用 | |
JP2016535005A (ja) | RoRyTのキノリニルモジュレーター | |
CN114401968A (zh) | 新颖杂环单酰基甘油脂肪酶(magl)抑制剂 | |
CN114269755A (zh) | 作为magl抑制剂的4,4a,5,7,8,8a-六吡啶并[4,3-b][1,4]噁嗪-3-酮化合物 | |
CN102977142A (zh) | 福沙匹坦二甲葡胺的制备方法 | |
CN114096545A (zh) | 新杂环化合物 | |
WO2016140501A1 (en) | Pyridine n-oxide for enhancer of zeste homolog 2 inhibitors | |
WO2022228544A1 (zh) | 异喹啉酮类化合物及其用途 | |
KR20210097161A (ko) | 헤모글로빈 조절제로서의 피라졸 | |
CN112341377A (zh) | 一种杂环类化合物及其应用 | |
US8975397B2 (en) | Solid forms | |
WO2021230198A1 (ja) | ジヒドロキノリノン化合物の共結晶 | |
CN102443009B (zh) | 并环激酶抑制剂 | |
CN107428682B (zh) | 酰胺类衍生物、其制备方法及其在医药上的用途 | |
CN114075139A (zh) | 五元杂芳环类化合物及其在药物中的应用 | |
TW202144358A (zh) | 用作ret激酶抑制劑的化合物及其應用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant |